What is Inovio Pharmaceuticals, Inc.'s Market Cap?

Inovio Pharmaceuticals, Inc.'s Market Cap is $92.8M, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Enterprise Value?

Inovio Pharmaceuticals, Inc.'s Enterprise Value is $56.1M, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s EV / EBITDA?

Inovio Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Revenue (TTM)?

Inovio Pharmaceuticals, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Net Income (TTM)?

Inovio Pharmaceuticals, Inc.'s Net Income (TTM) is -$67.4M, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s EBITDA?

Inovio Pharmaceuticals, Inc.'s EBITDA is -$77.9M, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

Inovio Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -0.65, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Net Debt?

Inovio Pharmaceuticals, Inc.'s Net Debt is -$36.7M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Inovio Pharmaceuticals, Inc.

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S5RHZ0

0.90▲ 0.06 (6.94%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 0.84
Day's Range: 0.80 – 0.94
52-Week Range: 0.56 – 2.72
Volume: 3.9M
Avg Volume: 3.3M

Share Statistics

Shares Outstanding
Employees: 112
Exchange: XNAS
Listed: 1998-12-08

Share count as of August 10, 2026

Inovio Pharmaceuticals, Inc. (INO) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Inovio Pharmaceuticals, Inc. (INO)

What is Inovio Pharmaceuticals, Inc.'s Market Cap?: Inovio Pharmaceuticals, Inc.'s Market Cap is $92.8M, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Enterprise Value?: Inovio Pharmaceuticals, Inc.'s Enterprise Value is $56.1M, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s EV / EBITDA?: Inovio Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Revenue (TTM)?: Inovio Pharmaceuticals, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Net Income (TTM)?: Inovio Pharmaceuticals, Inc.'s Net Income (TTM) is -$67.4M, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s EBITDA?: Inovio Pharmaceuticals, Inc.'s EBITDA is -$77.9M, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: Inovio Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -0.65, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Net Debt?: Inovio Pharmaceuticals, Inc.'s Net Debt is -$36.7M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · INOAs-filed SEC (XBRL) data